These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Photodynamic therapy of superficial tumors and carcinoma in situ of the bladder]. Hisazumi H; Ueki O; Kumaki O; Naito K; Misaki T Gan No Rinsho; 1985 May; 31(6 Suppl):697-703. PubMed ID: 4032754 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. Prout GR; Lin CW; Benson R; Nseyo UO; Daly JJ; Griffin PP; Kinsey J; Tian ME; Lao YH; Mian YZ N Engl J Med; 1987 Nov; 317(20):1251-5. PubMed ID: 2959863 [TBL] [Abstract][Full Text] [Related]
7. [Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder--report of 30 cases]. Tian ME Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):304-6. PubMed ID: 2533889 [TBL] [Abstract][Full Text] [Related]
8. [Improved argon laser photodynamic therapy for superficial bladder tumor--experimental research and clinical analysis]. Guo YC Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):75-7. PubMed ID: 2142071 [TBL] [Abstract][Full Text] [Related]
9. Whole bladder photodynamic therapy for transitional cell carcinoma of bladder. Nseyo UO; Dougherty TJ; Boyle DG; Potter WR; Wolf R; Huben R; Pontes JE Urology; 1985 Sep; 26(3):274-80. PubMed ID: 2930927 [TBL] [Abstract][Full Text] [Related]
10. Integral laser-photodynamic treatment of multifocal bladder carcinoma photosensitized by hematoporphyrin derivative. Jocham D; Schmiedt E; Baumgartner R; Unsöld E Eur Urol; 1986; 12 Suppl 1():43-6. PubMed ID: 2945724 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy. Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222 [TBL] [Abstract][Full Text] [Related]
13. Treatment of diffuse transitional cell carcinoma in situ by whole bladder hematoporphyrin derivative photodynamic therapy. Benson RC J Urol; 1985 Oct; 134(4):675-8. PubMed ID: 3162038 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. Nseyo UO; Shumaker B; Klein EA; Sutherland K J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601 [TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?]. Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium. Manyak MJ; Ogan K J Endourol; 2003 Oct; 17(8):633-9. PubMed ID: 14622483 [TBL] [Abstract][Full Text] [Related]
19. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo. Bellnier DA; Prout GR; Lin CW J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065 [TBL] [Abstract][Full Text] [Related]